14 infectious diseases stories you may have missed in 2021 - Healio
December 19, 2021
3 min read
Stories that focused on emerging research and breaking news related to COVID-19 dominated headlines in 2021.
Below is a list of the top stories from 2021 for each infectious disease subspecialty covered by Healio writers that were not related to COVID-19.
Exposure to common nonantimicrobial drugs may lead to drug-resistant infections (Antimicrobials)
Exposure to commonly prescribed nonantimicrobial drugs was associated with an increased risk for drug-resistant infections in a study of more than 1,800 patients at an Israeli hospital. Read more.
FDA approves Dalvance for pediatric ABSSSI treatment (Dermatology)
The FDA approved AbbVie's Dalvance (dalbavancin) for the treatment of acute bacterial skin and skin structure infections in pediatric patients from birth. Read more.
IDSA, SHEA update guidance for managing patients with C. difficile (Gastrointestinal Infections)
The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America released new guidelines for the management of Clostridioides difficile. The guidance, which was published in Clinical Infectious Diseases, offers recommendations for providers caring for adults with C. difficile infection, including infectious diseases specialists, gastroenterologists, hospitalists and pharmacists. Read more.
'We must redouble our efforts': More signs HCV care has suffered during pandemic (Hepatitis C)
Because of pandemic-related disruptions in hepatitis C care, researchers said thousands of cases will remain unidentified with fewer patients initiating care and achieving SVR. Read more.
Q&A: 40 years with the 'amazing evil' of HIV/AIDS (HIV/AIDS)
June 5 marked 40 years since MMWR published the first report of what would come to be called AIDS. Healio spoke with Infectious Disease News Chief Medical Editor Paul A. Volberding, MD, about the early years of the HIV/AIDS epidemic and what the future holds. Volberding was at the forefront of the early epidemic in San Francisco as a physician at San Francisco General Hospital. Read more.
Moderna begins first study of mRNA vaccine for flu (Influenza)
Moderna announced the start of a phase 1/2 study that will evaluate an investigational messenger RNA vaccine for influenza. Read more.
Simpler, one-swab iodophor regimen reduces MRSA carriage (MRSA)
A simpler one-swab-per nostril iodophor regimen produced identical reductions in MRSA carriage among nursing home residents as a two-swab regimen. Read more.
Beta-lactams before vancomycin reduces mortality from bloodstream infections (Nosocomial Infections)
Administering a beta-lactam antibiotic before vancomycin significantly reduced mortality rates among patients being treated for bloodstream infections. Read more.
In children with pneumonia, short course of antibiotics comparable to long course (Pediatric ID)
A 5-day course of antibiotics was just as effective as the standard 10-day course in treating community-associated pneumonia in nonhospitalized children. Read more.
Racial, socioeconomic gaps apparent in telemedicine (Practice Management)
Older, Asian and non-English-speaking patients were less likely to use telemedicine during the early days of the pandemic. Additionally, Black, Latinx and poorer patients were less likely to use video during telemedicine visits, as opposed to the phone, suggesting there are gaps in telemedicine care that may require attention. Read more.
Shorter antibiotic therapy noninferior to longer therapy for community-acquired pneumonia (Respiratory Infections)
Three days of antibiotic therapy was noninferior to 8 days of therapy for patients with moderately severe community-acquired pneumonia. Read more.
CDC updates STI treatment guidelines for first time since 2015 (STDs)
The CDC published updated clinical guidelines for the treatment of STIs amid a sustained national increase in cases of chlamydia, gonorrhea and syphilis. The guidance, updated for the first time since 2015, also included prevention strategies and diagnostic recommendations. Read more.
FDA approves trivalent hepatitis B vaccine for adults (Vaccination)
VBI Vaccines announced that the FDA has approved the company's recombinant trivalent hepatitis B vaccine, PreHevbrio, for adults aged 18 years or older. It is the only approved three-antigen HBV vaccine for adults. Read more.
CDC confirms second travel-related case of monkeypox in US this year (Zoonotic Infections)
In November, the CDC confirmed that another traveler returning to the United States from Nigeria was diagnosed with monkeypox. It was the second confirmed case of human monkeypox in a U.S. citizen who traveled from Nigeria this year, the first of which was reported in July in Texas. Read more.
Comments
Post a Comment